CYTEC INDS INC (CYT)
(Delayed Data from NYSE)
$75.17 USD
+0.02 (0.03%)
Updated Dec 8, 2015 04:01 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Cyteir Therapeutics, Inc. [CYT]
Reports for Purchase
Showing records 1 - 20 ( 156 total )
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Q1 Financials; Preliminary CY-0851 Mono and Combination Data Ahead at ASCO
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
ASCO 2023 Abstract Titles for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Q3 Financials; Initial Ph 2 Data Ahead in Q1; Combinations Look in 1H:23
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Biotechnology- EORTC-NCI-AACR 2022: Covered Companies Roundup
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Reports of the Death of Synthetic Lethality are Grossly Exaggerated
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Q2 Financials; TNBC Cohort Opened with Additional Study Tweaks; Runway Extended
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
ASCO 2022 Roundup for Covered Companies (Part 1)
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Q1 Financials; CYT-0851 Mechanism Clarified; Trials Remain on Track
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
R&D Day; CYT-0851 Target Identified; Strategy on Clear Track
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Company: Cyteir Therapeutics, Inc.
Industry: Medical - Drugs
Q4 Financials; Data Rich Year Ahead; Expansion and Combo Cohorts Underway
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R